As expected, the levels of Fxn did not approach that of WT fibroblasts as the genetic mutation harbored in FRDA patient cells already shows a >50% decrease in Fxn due to reduced FXN mRNA levels. The gene discussed is FXN; the disease is Friedreich ataxia.